These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 4041165

  • 1. [Complete remission of bladder cancer with multiple pulmonary metastases obtained by combined chemotherapy with cis-platinum, adriamycin and cyclophosphamide].
    Takigawa H, Odachi M, Kagawa S, Kurokawa K.
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1877-9. PubMed ID: 4041165
    [Abstract] [Full Text] [Related]

  • 2. [Complete response of lung metastasis from bladder cancer by combination chemotherapy with methotrexate, epirubicin and cisplatin: a case report].
    Oouchi H, Noguchi S, Masuda M, Shuin T, Kubota Y, Hosaka M.
    Hinyokika Kiyo; 1995 Mar; 41(3):227-30. PubMed ID: 7741078
    [Abstract] [Full Text] [Related]

  • 3. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T.
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [Abstract] [Full Text] [Related]

  • 4. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
    de Vries RR, Nieuwenhuijzen JA, Meinhardt W, Bais EM, Horenblas S.
    Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
    [Abstract] [Full Text] [Related]

  • 5. Optimal scheduling of interleukin 12 and chemotherapy in the murine MB-49 bladder carcinoma and B16 melanoma.
    Teicher BA, Ara G, Buxton D, Leonard J, Schaub RG.
    Clin Cancer Res; 1997 Sep; 3(9):1661-7. PubMed ID: 9815857
    [Abstract] [Full Text] [Related]

  • 6. [Combination chemotherapy of advanced bladder cancer].
    Kiyohara H.
    Hinyokika Kiyo; 1986 Dec; 32(12):1925-30. PubMed ID: 3825829
    [Abstract] [Full Text] [Related]

  • 7. [Combination chemotherapy of advanced transitional cell carcinoma with cis-platinum, cyclophosphamide, adriamycin and 5-fluorouracil (CISCAF)].
    Fujioka H, Tada Y, Nakano E, Matsuda M, Osafune M, Sagawa S, Takaha M, Sonoda T.
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1612-6. PubMed ID: 6541019
    [Abstract] [Full Text] [Related]

  • 8. [Complete remission of lung metastases of bladder tumor treated by small dosage of UFT: a case report].
    Fukuoka H, Takeda M, Nomura S, Ogawa T, Sakanishi S.
    Hinyokika Kiyo; 1991 May; 37(5):541-4. PubMed ID: 1858591
    [Abstract] [Full Text] [Related]

  • 9. [Complete remission of brain metastasis of bladder cancer treated by M-VAC therapy].
    Nakagawa S, Nakao M, Toyoda K, Nukui M, Takada H, Ebisui K.
    Hinyokika Kiyo; 1989 Feb; 35(2):333-5. PubMed ID: 2735244
    [Abstract] [Full Text] [Related]

  • 10. [Aggressive preoperative chemotherapy in infiltrating bladder carcinoma with a combination of cisplatin, cyclophosphamide and adriamycin. Preliminary report].
    Martínez-Piñeiro JA, de la Peña JJ, Hidalgo L, Cisneros J, Jiménez de León J, Machuca J.
    Arch Esp Urol; 1986 Feb; 39(1):33-46. PubMed ID: 3707210
    [No Abstract] [Full Text] [Related]

  • 11. [Therapeutic experiences of cis-diamminedichloroplatinum, adriamycin and 5-fluorouracil combination chemotherapy in advanced urothelial cancer, with special reference to adjuvant chemotherapy in invasive urothelial cancer].
    Ogawa O, Yoshimura N, Taniguchi T, Nishimura K, Nakagawa T.
    Hinyokika Kiyo; 1986 Jun; 32(6):795-802. PubMed ID: 3766338
    [Abstract] [Full Text] [Related]

  • 12. Pre-cystectomy chemotherapy with sequentially administered cisplatin, cyclophosphamide and adriamycin in invasive transitional cell carcinoma of the bladder (preliminary report).
    Guazzieri S, Sperandio P, Fandella A, Garbeglio A, Pegoraro V, Chiarion V, Fiorentino M, Pagano F.
    Prog Clin Biol Res; 1988 Jun; 260():599-602. PubMed ID: 3362909
    [No Abstract] [Full Text] [Related]

  • 13. [Complete remission of recurrent ovarian dysgerminoma obtained by combined chemotherapy with cisplatin, adriamycin and cyclophosphamide].
    Yokota H, Saito M, Tsunoda H, Kawagoe K.
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):151-4. PubMed ID: 4038447
    [Abstract] [Full Text] [Related]

  • 14. [A case of carcinomatous meningitis from transitional cell carcinoma of the urinary bladder].
    Hara Y, Kobayashi Y, Goto K, Tozuka K, Tokue A, Mochizuki M.
    Hinyokika Kiyo; 1994 Dec; 40(12):1113-7. PubMed ID: 7863865
    [Abstract] [Full Text] [Related]

  • 15. [Characteristic and effective usage of adriamycin].
    Horiuchi K, Akimoto M.
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1916-9. PubMed ID: 8978797
    [Abstract] [Full Text] [Related]

  • 16. [Effect of combination chemotherapy of tegafur, adriamycin and cisplatin on patients with advanced relapsing prostatic carcinoma and advanced bladder tumor].
    Yoshida K, Nakame Y, Horiuchi S, Kaneoya F, Kuroda T, Tanoiri A, Koizumi M, Takahashi M, Negishi T, Saitoh H.
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1083-5. PubMed ID: 3083786
    [No Abstract] [Full Text] [Related]

  • 17. Methotrexate, vinblastine, adriamycin and cisplatin (MVAC) chemotherapy for the treatment of advanced bladder carcinoma.
    Balbay MD, Ozen H, Uluçay S, Sahin A, Ergen A, Koçal C, Remzi D.
    Int Urol Nephrol; 1993 Apr; 25(4):351-7. PubMed ID: 8276565
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of chemotherapy in advanced urothelial carcinoma: with special reference to combination chemotherapy with adriamycin, cyclophosphamide and cisplatin (ACE chemotherapy)].
    Tobisu K, Matsumoto K, Takai K, Kakizoe T.
    Nihon Hinyokika Gakkai Zasshi; 1987 Feb; 78(2):327-34. PubMed ID: 3613336
    [No Abstract] [Full Text] [Related]

  • 19. [Systemic cisplatin-based chemotherapy in the treatment of advanced bladder cancer].
    Boccon-Gibod L, Guinet F, Cressey-Kanoui C, Debré B, Steg A.
    Ann Urol (Paris); 1985 Feb; 19(4):239-43. PubMed ID: 4040730
    [Abstract] [Full Text] [Related]

  • 20. Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer--phase I/II study.
    Yoshida O, Kakehi Y, Arai Y, Tomoyoshi T, Okada Y, Matsuda T, Mikami O, Fukuyama T, Hida S, Okabe T.
    Int J Urol; 1995 Nov; 2(5):316-21. PubMed ID: 8749950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.